Join
Live feed
·
INSIDERFilingvia Quantisnow
VYNE Therapeutics Inc. logo

PRESIDENT AND CEO Domzalski David was granted 30,791 shares, increasing direct ownership by 8% to 438,779 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VYNE· VYNE Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYNE (VYNE Therapeutics Inc.) and more on Quantisnow.